Greater Occipital Nerve Block With Bupivacaine for Acute Migraine

Summary

This is a randomized, sham-controlled study of greater occipital nerve block (GONB) using bupivacaine 0.5% for emergency department patients with acute migraine. Patients are only enrolled if they fail first line therapy with metoclopramide.

Timeline

Start

2015-07-01

Primary completion

2018-01

Completion

2018-01

Drugs

Indications